Top

Journal of Interventional Cardiac Electrophysiology

Published in:

01-06-2009

Epidemiology of atrial fibrillation

Author: Michael W. Rich

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 1/2009

Abstract

The incidence and prevalence of atrial fibrillation (AF) increase progressively with age, and approximately 50% of patients with AF are 75 years of age or older. Advanced age is also a potent risk factor for stroke in patients with AF, and the proportion of strokes attributable to AF increases exponentially with age. In addition, AF contributes incrementally to health care utilization and costs, and decrementally to survival and quality of life in older adults. Furthermore, the societal impact of AF will likely double over the next three decades due to the aging of the population. For these reasons, it is essential to develop more effective strategies for the prevention and treatment of AF in older individuals.

Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. Journal of the American Medical Association, 285, 2370–2375.PubMedCrossRef

Rosamond, W., Flegal, K., Friday, G., et al. (2007). Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 115, e69–e171.PubMedCrossRef

Wattigney, W. A., Mensah, G. A., & Croft, J. B. (2003). Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation, 108, 711–716.PubMedCrossRef

Coyne, K. S., Paramore, C., Grandy, S., Mercader, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9, 348–356.PubMedCrossRef

Wolf, P. A., Mitchell, J. B., Baker, C. S., Kannel, W. B., & D’Agostino, R. B. (1998). Impact of atrial fibrillation on mortality, stroke, and medical costs. Archives of Internal Medicine, 158, 229–234.PubMedCrossRef

Psaty, B. M., Manolio, T. A., Kuller, L. H., et al. (1997). Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 96, 2455–2461.PubMed

Miyasaka, Y., Barnes, M. E., Gersh, B. J., et al. (2006). Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980–2000, and implications on the projections for future prevalence. Circulation, 114, 119–125.PubMedCrossRef

Feinberg, W. M., Blackshear, J. L., Laupacis, A., Kronmal, R., & Hart, R. G. (1995). Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Archives of Internal Medicine, 155, 469–473.PubMedCrossRef

Benjamin, E. J., Levy, D., Vaziri, S. M., D’Agostino, R. B., Belanger, A. J., & Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Journal of the American Medical Association, 271, 840–844.PubMedCrossRef

10.

Vaziri, S. M., Larson, M. G., Benjamin, E. J., & Levy, D. (1994). Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation, 89, 724–730.PubMed

11.

Djousse, L., Levy, D., Benjamin, E. J., et al. (2004). Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. The American Journal of Cardiology, 93, 710–713.PubMedCrossRef

12.

Chen, L. Y., & Shen, W. K. (2007). Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm, 4(Suppl 3), S1–S6.PubMedCrossRef

13.

Lakatta, E., & Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation, 107, 139–146.PubMedCrossRef

14.

Lakatta, E. G., & Levy, D. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation, 107, 346–354.PubMedCrossRef

15.

Lakatta, E. G. (2003). Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation, 107, 490–497.PubMedCrossRef

16.

Anonymous (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Archives of Internal Medicine, 154, 1449–1457.CrossRef

17.

Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991). Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 22, 983–988.PubMed

18.

Fang, M. C., Singer, D. E., Chang, Y., et al. (2005). Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation, 112, 1687–1691.PubMedCrossRef

19.

Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Journal of the American Medical Association, 285, 2864–2870.PubMedCrossRef

20.

Franchini, M. (2006). Hemostasis and aging. Critical Reviews in Oncology/Hematology, 60(2), 144–151.PubMedCrossRef

21.

Wilkerson, W. R., & Sane, D. C. (2002). Aging and thrombosis. Seminars in Thrombosis and Hemostasis, 28, 555–568.PubMedCrossRef

22.

Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannal, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946–952.PubMed

Title: Epidemiology of atrial fibrillation
Author: Michael W. Rich
Publication date: 01-06-2009
Publisher: Springer US
Published in: Journal of Interventional Cardiac Electrophysiology / Issue 1/2009
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-008-9337-8

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Epidemiology of atrial fibrillation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Introduction

Electro-anatomical mapping of the left atrium before and after cryothermal balloon isolation of the pulmonary veins

Aged atria: electrical remodeling conducive to atrial fibrillation

Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications

Current state of knowledge and experts’ perspective on the subcutaneous implantable cardioverter-defibrillator

Ventricular arrhythmias originating from the epicardial ventricular outflow tract complicated with peripartum cardiomyopathy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page